How to add additional study drugs on open label study cases after bookin
(Doc ID 1320583.1)
Last updated on JULY 13, 2023
Applies to:
Oracle Life Sciences Argus Safety - Version 5.1.1 and laterInformation in this document applies to any platform.
Goal
When the open label study case is booked in and if the user selects "0" products from the dialog box to be added, one product is added from the study configuration. How can a user add an additional study drug to the case?
Solution
To view full details, sign in with your My Oracle Support account. |
|
Don't have a My Oracle Support account? Click to get started! |
In this Document
Goal |
Solution |